118 related articles for article (PubMed ID: 26977624)
21. [THE USE OF REMAXOL IN THE TREATMENT OF METABOLIC SYNDROME IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND DIABETES MELLITUS 2 TYPE].
Dudorenko SV; Kovalenko AL; Prokopenko SM; Belogurova EV
Eksp Klin Gastroenterol; 2016; (6):89-94. PubMed ID: 30280846
[TBL] [Abstract][Full Text] [Related]
22. [Pecularities of correction of alcohol affctions of liver in patients with acute ethanol poisoning in the setting of consequence of toxic effect of ethanol].
Shilov VV; batotsyrenov BV; Vasil'ev SA; Shikalova IA; Kuznetsov OA
Voen Med Zh; 2012 Jun; 333(6):38-41. PubMed ID: 22888700
[TBL] [Abstract][Full Text] [Related]
23. [Metaanalytic Approach to Evaluate Clinical Effectiveness of Infusion Succinnate-Containing Remaxol in Liver Pathologies of Diverse Genesis].
Mazina NK; Mazin PV
Antibiot Khimioter; 2015; 60(11-12):43-9. PubMed ID: 27141647
[TBL] [Abstract][Full Text] [Related]
24. Halazepam in the management of acute alcohol withdrawal syndrome.
Mendels J; Wasserman TW; Michals TJ; Fine EW
J Clin Psychiatry; 1985 May; 46(5):172-4. PubMed ID: 2859274
[TBL] [Abstract][Full Text] [Related]
25. [The clinical efficacy of a succinate-containing infusion drug during pharmacotherapy for hepatic lesions of varying genesis: results of meta-analysis].
Mazina NK; Mazin PV; Sukhanov DS
Ter Arkh; 2013; 85(1):56-61. PubMed ID: 23536947
[TBL] [Abstract][Full Text] [Related]
26. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
[TBL] [Abstract][Full Text] [Related]
27. [The efficacy of remaxol as a hepatoprotective agent in long-term psychopharmacotherapy].
Filippova NV; Barylnik YB; Shuldyakov AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(4):43-46. PubMed ID: 31156221
[TBL] [Abstract][Full Text] [Related]
28. [[Features of Pharmacological Correction of Alcoholic Fatty Liver Disease in Patients with Acute Ethanol Intoxication].].
Livanov GA; Shikalova IA; Lodyagin AN; Glushkov S; Batotsyrenov BV; Loladze AT; Kovalenko AL
Eksp Klin Gastroenterol; 2016; (5):45-50. PubMed ID: 28614644
[TBL] [Abstract][Full Text] [Related]
29. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
[TBL] [Abstract][Full Text] [Related]
30. A plea for abrupt alcohol withdrawal in the therapy of the acute alcohol withdrawal syndrome.
Miller BH
Va Med Mon (1918); 1968 Jul; 95(7):404-11. PubMed ID: 5665133
[No Abstract] [Full Text] [Related]
31. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
32. Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms.
Ubaldi M; Del Bello F; Domi E; Pigini M; Nasuti C
Eur J Pharmacol; 2015 Aug; 760():122-8. PubMed ID: 25895641
[TBL] [Abstract][Full Text] [Related]
33. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
[TBL] [Abstract][Full Text] [Related]
34. [Benzodiazepines in the treatment of alcoholism].
Ades J; Rodière C
Encephale; 1983; 9(4 Suppl 2):293B-298B. PubMed ID: 6373235
[TBL] [Abstract][Full Text] [Related]
35. [Integrated approach to correction enteral insufficiency in early postoperative period].
Vlasov AP; Salahov EK; Shibitov VA; Vlasov PA; Bolotskih VA
Khirurgiia (Mosk); 2016; (5):52-58. PubMed ID: 27271720
[TBL] [Abstract][Full Text] [Related]
36. Physostigmine in eyedrops decreases craving for alcohol in early withdrawal treated with carbamazepine.
Stojek A; Napierała K
Mater Med Pol; 1986; 18(4):249-54. PubMed ID: 3613684
[No Abstract] [Full Text] [Related]
37. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome.
Di Nicola M; Martinotti G; Tedeschi D; Frustaci A; Mazza M; Sarchiapone M; Pozzi G; Bria P; Janiri L
Hum Psychopharmacol; 2010 Apr; 25(3):268-75. PubMed ID: 20373479
[TBL] [Abstract][Full Text] [Related]
38. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting.
Elholm B; Larsen K; Hornnes N; Zierau F; Becker U
Alcohol Alcohol; 2011; 46(3):318-23. PubMed ID: 21414950
[TBL] [Abstract][Full Text] [Related]
39. [Aspects of the importance of postoperative hepatoprotector therapy in urgent surgery].
Fedoseev AV; Muraviev SU; Budarev VN; Inutin AS; Filonenko PS; Lebedev SN
Khirurgiia (Mosk); 2018; (4):77-83. PubMed ID: 29697689
[TBL] [Abstract][Full Text] [Related]
40. [Violations of oxygen transport function of hemoglobin in surgical endointoxication and their correction using remaxol].
Vlasov AP; Trofimov VA; Shibitov VA; Vlasov PA; Bolotskikh VA; Meleshkin AV; Chamatkina EM
Khirurgiia (Mosk); 2016; (2):55-60. PubMed ID: 26977869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
